nach oben

Current Reviews in Musculoskeletal Medicine

Erschienen in:

21.01.2020 | Stem Cells in Orthopaedic Surgery (J Dragoo and KJ Jones, Section Editors)

Stem Cell Treatment for Knee Articular Cartilage Defects and Osteoarthritis

verfasst von: Armin Arshi, Frank A. Petrigliano, Riley J. Williams, Kristofer J. Jones

Erschienen in: Current Reviews in Musculoskeletal Medicine | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

To review the current basic science and clinical literature on mesenchymal stem cell (MSC) therapy for articular cartilage defects and osteoarthritis of the knee.

Recent Findings

MSCs derived from bone marrow, adipose, and umbilical tissue have the capacity for self-renewal and differentiation into the chondrocyte lineage. In theory, MSC therapy may help restore cartilage focally or diffusely where nascent regenerative potential in the intra-articular environment is limited. Over the last several years, in vitro and animal studies have elucidated the use of MSCs in isolation as injectables, in combination with biological delivery media and scaffolding, and as surgical adjuvants for cartilage regeneration and treatment of knee degenerative conditions. More recently, clinical and translational literature has grown more convincing from early descriptive case series to randomized controlled trials showing promise in efficacy and safety. Studies describing MSC for knee cartilage regeneration applications are numerous and varied in quality. Future research directions should include work on elucidating optimal cell concentration and dosing, as well as standardization in methodology and reporting in prospective trials.

Summary

Backed by promise from in vitro and animal studies, preliminary clinical evidence on MSC therapy shows promise as a nonoperative therapeutic option or an adjuvant to existing surgical cartilage restoration techniques. While higher quality evidence to support MSC therapy has emerged over the last several years, further refinement of methodology will be necessary to support its routine clinical use.

Prieto-Alhambra D, Judge A, Javaid MK, Cooper C, Diez-Perez A, Arden NK. Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints. Ann Rheum Dis. 2014;73(9):1659–64.PubMed

Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(7):1323–30.PubMed

Jevsevar DS. Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg. 2013;21(9):571–6.PubMed

Bedard NA, DeMik DE, Glass NA, Burnett RA, Bozic KJ, Callaghan JJ. Impact of clinical practice guidelines on use of intra-articular hyaluronic acid and corticosteroid injections for knee osteoarthritis. J Bone Jt Surg. 2018;100(10):827–34.

Bergman RJ, Gazit D, Kahn AJ, Gruber H, McDougall S, Hahn TJ. Age-related changes in osteogenic stem cells in mice. J Bone Miner Res. 1996;11(5):568–77.PubMed

Knutsen G, Engebretsen L, Ludvigsen TC, et al. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J Bone Joint Surg Am. 2004;86-A(3):455–64.

Samsudin EZ, Kamarul T. The comparison between the different generations of autologous chondrocyte implantation with other treatment modalities: a systematic review of clinical trials. Knee Surgery, Sport Traumatol Arthrosc. 2016;24(12):3912–26.

Ebert JR, Edwards PK, Fallon M, Ackland TR, Janes GC, Wood DJ. Two-year outcomes of a randomized trial investigating a 6-week return to full weightbearing after matrix-induced autologous chondrocyte implantation. Am J Sports Med. 2017;45(4):838–48.PubMed

Fahy N, Alini M, Stoddart MJ. Mechanical stimulation of mesenchymal stem cells: implications for cartilage tissue engineering. J Orthop Res. 2017;36(1):52–63.PubMed

10.

Ghezzi CE, Marelli B, Donelli I, Alessandrino A, Freddi G, Nazhat SN. Multilayered dense collagen-silk fibroin hybrid: a platform for mesenchymal stem cell differentiation towards chondrogenic and osteogenic lineages. J Tissue Eng Regen Med. 2017;11(7):2046–59.PubMed

11.

Goldring MB, Tsuchimochi K, Ijiri K. The control of chondrogenesis. J Cell Biochem. 2006;97(1):33–44.PubMed

12.

Wang T, Nimkingratana P, Smith CA, Cheng A, Hardingham TE, Kimber SJ. Enhanced chondrogenesis from human embryonic stem cells. Stem Cell Res. 2019;39:101497.PubMedPubMedCentral

13.

Caron MMJ, Emans PJ, Cremers A, et al. Hypertrophic differentiation during chondrogenic differentiation of progenitor cells is stimulated by BMP-2 but suppressed by BMP-7. Osteoarthr Cartil. 2013;21(4):604–13.

14.

Heo JS, Choi Y, Kim H, Kim HO. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. Int J Mol Med. 2016;37(1):115–25.PubMed

15.

• Pas HI, Winters M, Haisma HJ, Koenis MJ, Tol JL, Moen MH. Stem cell injections in knee osteoarthritis: a systematic review of the literature. Br J Sports Med. 2017;51(15):1125–33 Systematic review summarizing recent randomized controlled trials on the use of MSC therapy for knee OA. The authors described six trials with high risk of bias that shows evidence in favor of MSC injections for knee OA. PubMed

16.

•• Nancarrow-Lei R, Mafi P, Mafi R, Khan W. A systemic review of adult mesenchymal stem cell sources and their multilineage differentiation potential relevant to musculoskeletal tissue repair and regeneration. Curr Stem Cell Res Ther. 2017;12(8):601–10 Comprehensive review of the sources and differentiation potential of MSCs for tissue engineering and regeneration of cartilage and other musculoskeletal tissues. PubMed

17.

Varghese J, Griffin M, Mosahebi A, Butler P. Systematic review of patient factors affecting adipose stem cell viability and function: implications for regenerative therapy. Stem Cell Res Ther. 2017;8(1):45.PubMedPubMedCentral

18.

Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–7.PubMed

19.

Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther. 2007;9(1):204.PubMedPubMedCentral

20.

Kuroda K, Kabata T, Hayashi K, et al. The paracrine effect of adipose-derived stem cells inhibits osteoarthritis progression. BMC Musculoskelet Disord. 2015;16(1):236.PubMedPubMedCentral

21.

Fong ELS, Chan CK, Goodman SB. Stem cell homing in musculoskeletal injury. Biomaterials. 2011;32(2):395–409.PubMed

22.

Zahari W, Hashim S, Yusof M, et al. Immunomodulatory effect of cytokines in the differentiation of mesenchymal stem cells: a review. Curr Stem Cell Res Ther. 2017;12(3):197–206.PubMed

23.

Ng J, Hynes K, White G, Sivanathan KN, Vandyke K, Bartold PM, et al. Immunomodulatory properties of induced pluripotent stem cell-derived mesenchymal cells. J Cell Biochem. 2016;117(12):2844–53.PubMed

24.

Hynes K, Bright R, Proudman S, Haynes D, Gronthos S, Bartold M. Immunomodulatory properties of mesenchymal stem cell in experimental arthritis in rat and mouse models: a systematic review. Semin Arthritis Rheum. 2016;46(1):1–19.PubMed

25.

Ozeki N, Muneta T, Koga H, Nakagawa Y, Mizuno M, Tsuji K, et al. Not single but periodic injections of synovial mesenchymal stem cells maintain viable cells in knees and inhibit osteoarthritis progression in rats. Osteoarthr Cartil. 2016;24(6):1061–70.

26.

Desando G, Giavaresi G, Cavallo C, et al. Autologous bone marrow concentrate in a sheep model of osteoarthritis: new perspectives for cartilage and meniscus repair. Tissue Eng Part C Methods. 2016;22(6):608–19.PubMed

27.

Chiang E-R, Ma H-L, Wang J-P, Liu C-L, Chen T-H, Hung S-C. Allogeneic mesenchymal stem cells in combination with hyaluronic acid for the treatment of osteoarthritis in rabbits. Li W-J, ed. PLoS One. 2016;11(2):e0149835.PubMedPubMedCentral

28.

Diekman BO, Wu C-L, Louer CR, Furman BD, Huebner JL, Kraus VB, et al. Intra-articular delivery of purified mesenchymal stem cells from C57BL/6 or MRL/MpJ superhealer mice prevents posttraumatic arthritis. Cell Transplant. 2013;22(8):1395–408.PubMed

29.

Lv X, He J, Zhang X, Luo X, He N, Sun Z, et al. Comparative efficacy of autologous stromal vascular fraction and autologous adipose-derived mesenchymal stem cells combined with hyaluronic acid for the treatment of sheep osteoarthritis. Cell Transplant. 2018;27(7):1111–25.PubMedPubMedCentral

30.

Xia T, Yu F, Zhang K, et al. The effectiveness of allogeneic mesenchymal stem cells therapy for knee osteoarthritis in pigs. Ann Transl Med. 2018;6(20):404.PubMedPubMedCentral

31.

Yun S, Ku S-K, Kwon Y-S. Adipose-derived mesenchymal stem cells and platelet-rich plasma synergistically ameliorate the surgical-induced osteoarthritis in beagle dogs. J Orthop Surg Res. 2016;11(1):9.PubMedPubMedCentral

32.

Feng C, Luo X, He N, Xia H, Lv X, Zhang X, et al. Efficacy and persistence of allogeneic adipose-derived mesenchymal stem cells combined with hyaluronic acid in osteoarthritis after intra-articular injection in a sheep model. Tissue Eng Part A. 2018;24(3–4):219–33.PubMed

33.

Zhou J, Wang Y, Liu Y, Zeng H, Xu H, Lian F. Adipose derived mesenchymal stem cells alleviated osteoarthritis and chondrocyte apoptosis through autophagy inducing. J Cell Biochem. 2018;120(2):2198–212.

34.

Saulnier N, Viguier E, Perrier-Groult E, Chenu C, Pillet E, Roger T, et al. Intra-articular administration of xenogeneic neonatal mesenchymal stromal cells early after meniscal injury down-regulates metalloproteinase gene expression in synovium and prevents cartilage degradation in a rabbit model of osteoarthritis. Osteoarthr Cartil. 2015;23(1):122–33.

35.

Sasaki T, Akagi R, Akatsu Y, Fukawa T, Hoshi H, Yamamoto Y, et al. The effect of systemic administration of G-CSF on a full-thickness cartilage defect in a rabbit model MSC proliferation as presumed mechanism: G-CSF for cartilage repair. Bone Joint Res. 2017;6(3):123–31.PubMedPubMedCentral

36.

Harada Y, Nakasa T, Mahmoud EE, Kamei G, Adachi N, Deie M, et al. Combination therapy with intra-articular injection of mesenchymal stem cells and articulated joint distraction for repair of a chronic osteochondral defect in the rabbit. J Orthop Res. 2015;33(10):1466–73.PubMed

37.

• Mahmoud EE, Adachi N, Mawas AS, Deie M, Ochi M. Multiple intra-articular injections of allogeneic bone marrow-derived stem cells potentially improve knee lesions resulting from surgically induced osteoarthritis: an animal study. Bone Joint J. 2019;101-B(7):824–31 Small animal osteoarthritis model that demonstrates superiority of multiple allogeneic marrow-derived MSC injections compared with single injection both histologically and morphologically. PubMed

38.

Hermeto LC, DeRossi R, Oliveira RJ, et al. Effects of intra-articular injection of mesenchymal stem cells associated with platelet-rich plasma in a rabbit model of osteoarthritis. Genet Mol Res. 2016;15(3).

39.

• Rai V, Dilisio MF, Dietz NE, Agrawal DK. Recent strategies in cartilage repair: a systemic review of the scaffold development and tissue engineering. J Biomed Mater Res A. 2017;105(8):2343–54 Comprehensive review that describes recent challenges and developments in scaffolding adjuvants for MSC delivery for cartilage repair from a tissue engineering perspective. PubMed

40.

Lin X, Wang W, Zhang W, Zhang Z, Zhou G, Cao Y, et al. Hyaluronic acid coating enhances biocompatibility of nonwoven PGA scaffold and cartilage formation. Tissue Eng Part C Methods. 2017;23(2):86–97.PubMed

41.

Muhonen V, Salonius E, Haaparanta A-M, Järvinen E, Paatela T, Meller A, et al. Articular cartilage repair with recombinant human type II collagen/polylactide scaffold in a preliminary porcine study. J Orthop Res. 2016;34(5):745–53.PubMed

42.

Qi Y, Du Y, Li W, Dai X, Zhao T, Yan W. Cartilage repair using mesenchymal stem cell (MSC) sheet and MSCs-loaded bilayer PLGA scaffold in a rabbit model. Knee Surg Sports Traumatol Arthrosc. 2014;22(6):1424–33.PubMed

43.

Liu Y, Tian K, Hao J, Yang T, Geng X, Zhang W. Biomimetic poly(glycerol sebacate)/polycaprolactone blend scaffolds for cartilage tissue engineering. J Mater Sci Mater Med. 2019;30(5):53.PubMed

44.

Christensen BB, Foldager CB, Hansen OM, et al. A novel nano-structured porous polycaprolactone scaffold improves hyaline cartilage repair in a rabbit model compared to a collagen type I/III scaffold: in vitro and in vivo studies. Knee Surg Sports Traumatol Arthrosc. 2012;20(6):1192–204.PubMed

45.

Gardner OFW, Musumeci G, Neumann AJ, Eglin D, Archer CW, Alini M, et al. Asymmetrical seeding of MSCs into fibrin-poly(ester-urethane) scaffolds and its effect on mechanically induced chondrogenesis. J Tissue Eng Regen Med. 2017;11(10):2912–21.PubMed

46.

Pot MW, de Kroon LMG, van der Kraan PM, van Kuppevelt TH, Daamen WF. Unidirectional BMP2-loaded collagen scaffolds induce chondrogenic differentiation. Biomed Mater. 2017;13(1):015007.PubMed

47.

Recha-Sancho L, Semino CE. Heparin-based self-assembling peptide scaffold reestablish chondrogenic phenotype of expanded de-differentiated human chondrocytes. J Biomed Mater Res A. 2016;104(7):1694–706.PubMed

48.

Man Z, Hu X, Liu Z, Huang H, Meng Q, Zhang X, et al. Transplantation of allogenic chondrocytes with chitosan hydrogel-demineralized bone matrix hybrid scaffold to repair rabbit cartilage injury. Biomaterials. 2016;108:157–67.PubMed

49.

• Snow M, Williams R, Pagkalos J, Grover L. An in vitro study to determine the feasibility of combining bone marrow concentrate with BST-CarGel as a treatment for cartilage repair. Cartilage. 2018;1947603518812564 In vitro study demonstrating retention of implanted MSCs in chondral defects using a combination of BST-CarGel® and bone marrow aspirate concentrate.

50.

Stanish WD, McCormack R, Forriol F, et al. Novel scaffold-based BST-CarGel treatment results in superior cartilage repair compared with microfracture in a randomized controlled trial. J Bone Jt Surg Am. 2013;95(18):1640–50.

51.

Xing D, Kwong J, Yang Z, Hou Y, Zhang W, Ma B, et al. Intra-articular injection of mesenchymal stem cells in treating knee osteoarthritis: a systematic review of animal studies. Osteoarthr Cartil. 2018;26(4):445–61.

52.

Al-Najar M, Khalil H, Al-Ajlouni J, et al. Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study. J Orthop Surg Res. 2017;12(1):190.PubMedPubMedCentral

53.

Garay-Mendoza D, Villarreal-Martínez L, Garza-Bedolla A, Pérez-Garza DM, Acosta-Olivo C, Vilchez-Cavazos F, et al. The effect of intra-articular injection of autologous bone marrow stem cells on pain and knee function in patients with osteoarthritis. Int J Rheum Dis. 2018;21(1):140–7.PubMed

54.

Lamo-Espinosa JM, Mora G, Blanco JF, Granero-Moltó F, Nuñez-Córdoba JM, Sánchez-Echenique C, et al. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II). J Transl Med. 2016;14(1):246.PubMedPubMedCentral

55.

Jo CH, Lee YG, Shin WH, Kim H, Chai JW, Jeong EC, et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem Cells. 2014;32(5):1254–66.PubMed

56.

Jo CH, Chai JW, Jeong EC, et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a 2-year follow-up study. Am J Sports Med. 2017;45(12):2774–83.PubMed

57.

Song Y, Du H, Dai C, et al. Human adipose-derived mesenchymal stem cells for osteoarthritis: a pilot study with long-term follow-up and repeated injections. Regen Med. 2018;13(3):295–307.PubMed

58.

Pers Y-M, Rackwitz L, Ferreira R, Pullig O, Delfour C, Barry F, et al. Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: a phase I dose-escalation trial. Stem Cells Transl Med. 2016;5(7):847–56.PubMedPubMedCentral

59.

• Gupta PK, Chullikana A, Rengasamy M, et al. Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint. Arthritis Res Ther. 2016;18(1):301 Preclinical and clinical trial describing the use of Stempeucel® marrow-derived, allogeneic MSC injection for knee OA. PubMedPubMedCentral

60.

Vega A, Martín-Ferrero MA, Del Canto F, et al. Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial. Transplantation. 2015;99(8):1681–90.PubMed

61.

Park Y-B, Ha C-W, Lee C-H, Yoon YC, Park Y-G. Cartilage regeneration in osteoarthritic patients by a composite of allogeneic umbilical cord blood-derived mesenchymal stem cells and hyaluronate hydrogel: results from a clinical trial for safety and proof-of-concept with 7 years of extended follow-up. Stem Cells Transl Med. 2017;6(2):613–21.PubMed

62.

•• Matas J, Orrego M, Amenabar D, et al. Umbilical cord-derived mesenchymal stromal cells (MSCs) for knee osteoarthritis: repeated MSC dosing is superior to a single MSC dose and to hyaluronic acid in a controlled randomized phase I/II trial. Stem Cells Transl Med. 2019;8(3):215–24 Randomized controlled clinical trial that demonstrates superiority in clinical outcomes of repeated MSC dosing compared with single MSC dosing. PubMed

63.

Betsch M, Schneppendahl J, Thuns S, et al. Bone marrow aspiration concentrate and platelet rich plasma for osteochondral repair in a porcine osteochondral defect model. Neves NM, ed. PLoS One. 2013;8(8):e71602.PubMedPubMedCentral

64.

Koh Y-G, Kwon O-R, Kim Y-S, Choi Y-J, Tak D-H. Adipose-derived mesenchymal stem cells with microfracture versus microfracture alone: 2-year follow-up of a prospective randomized trial. Arthrosc J Arthrosc Relat Surg. 2016;32(1):97–109

65.

Koh Y-G, Kwon O-R, Kim Y-S, Choi Y-J. Comparative outcomes of open-wedge high tibial osteotomy with platelet-rich plasma alone or in combination with mesenchymal stem cell treatment: a prospective study. Arthroscopy. 2014;30(11):1453–60.PubMed

66.

Koh Y-G, Jo S-B, Kwon O-R, et al. Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthrosc J Arthrosc Relat Surg. 2013;29(4):748–55.

67.

Koh Y-G, Choi Y-J. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee. 2012;19(6):902–7.PubMed

68.

Bansal H, Comella K, Leon J, et al. Intra-articular injection in the knee of adipose derived stromal cells (stromal vascular fraction) and platelet rich plasma for osteoarthritis. J Transl Med. 2017;15(1):141.PubMedPubMedCentral

69.

Gibbs N, Diamond R, Sekyere EO, Thomas WD. Management of knee osteoarthritis by combined stromal vascular fraction cell therapy, platelet-rich plasma, and musculoskeletal exercises: a case series. J Pain Res. 2015;8:799–806.PubMedPubMedCentral

70.

Wong KL, Lee KBL, Tai BC, Law P, Lee EH, Hui JHP. Injectable cultured bone marrow–derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years’ follow-up. Arthrosc J Arthrosc Relat Surg. 2013;29(12):2020–8.

71.

Freitag J, Ford J, Bates D, Boyd R, Hahne A, Wang Y, et al. Adipose derived mesenchymal stem cell therapy in the treatment of isolated knee chondral lesions: design of a randomised controlled pilot study comparing arthroscopic microfracture versus arthroscopic microfracture combined with postoperative mesenchymal. BMJ Open. 2015;5(12):e009332.PubMedPubMedCentral

72.

•• Peeters CMM, Leijs MJC, Reijman M, van Osch GJVM, Bos PK. Safety of intra-articular cell-therapy with culture-expanded stem cells in humans: a systematic literature review. Osteoarthr Cartil. 2013;21(10):1465–73 Systematic literature review reviews side effects and complications associated with injectable intra-articular MSC therapies.

73.

Yubo M, Yanyan L, Li L, Tao S, Bo L, Lin C. Clinical efficacy and safety of mesenchymal stem cell transplantation for osteoarthritis treatment: a meta-analysis. Hills RK, ed. PLoS One. 2017;12(4):e0175449.PubMedPubMedCentral

74.

•• Piuzzi NS, Ng M, Chughtai M, et al. The stem-cell market for the treatment of knee osteoarthritis: a patient perspective. J Knee Surg. 2018;31(6):551–6 Cross-sectional study that assesses the cost and purported clinical efficacy of centers offering MSC therapy in the USA, which may help identify discrepancies between marketing and evidence-based practice. PubMed

75.

Sipp D, Caulfield T, Kaye J, et al. Marketing of unproven stem cell-based interventions: a call to action. Sci Transl Med. 2017;9(397):eaag0426.PubMed

76.

• Chu CR, Rodeo S, Bhutani N, et al. Optimizing clinical use of biologics in orthopaedic surgery. J Am Acad Orthop Surg. 2019;27(2):e50–63 Consensus statement from the AAOS and NIH on recommendations for minimal standards of product characterization and clinical research on biologics in orthopedic surgery. PubMed

77.

Hatsushika D, Muneta T, Nakamura T, Horie M, Koga H, Nakagawa Y, et al. Repetitive allogeneic intraarticular injections of synovial mesenchymal stem cells promote meniscus regeneration in a porcine massive meniscus defect model. Osteoarthr Cartil. 2014;22(7):941–50.

Titel: Stem Cell Treatment for Knee Articular Cartilage Defects and Osteoarthritis
verfasst von: Armin Arshi
Frank A. Petrigliano
Riley J. Williams
Kristofer J. Jones
Publikationsdatum: 21.01.2020
Verlag: Springer US
Erschienen in: Current Reviews in Musculoskeletal Medicine / Ausgabe 1/2020
Elektronische ISSN: 1935-9748
DOI: https://doi.org/10.1007/s12178-020-09598-z

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

25.04.2024 | Hypertonie | Nachrichten

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Stem Cell Treatment for Knee Articular Cartilage Defects and Osteoarthritis

Abstract

Purpose of Review

Recent Findings

Summary

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Ärztliche Empathie hilft gegen Rückenschmerzen

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Update Orthopädie und Unfallchirurgie

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

ACL and Posterolateral Corner Injuries

Osteoarthritis and ACL Reconstruction—Myths and Risks

Operative Versus Non-operative Management of Mid-diaphyseal Clavicle Fractures in the Skeletally Immature Population: A Systematic Review and Meta-analysis

Gait Retraining as an Intervention for Patellofemoral Pain

Dry Needling as a Treatment Modality for Tendinopathy: a Narrative Review

Advances and Update on Reverse Total Shoulder Arthroplasty

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Ärztliche Empathie hilft gegen Rückenschmerzen

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Update Orthopädie und Unfallchirurgie